Clinical trials in Turin – page 47

Clinical trials in cardiovascular disease and intensive care are evaluating ways to improve survival, reduce bleeding risk, and strengthen symptom control in seriously ill patients. In Torino, this includes studies focused on heart inflammation, irregular heartbeat after stent treatment, and ventilation strategies for critically ill adults.

• Acute myocarditis and pericarditis
• Atrial fibrillation after PCI
• Mechanically ventilated critically ill patients
• Goal of improving safety and treatment effectiveness

These studies are helping refine supportive care and test more effective approaches for common and potentially serious cardiac and critical care conditions.

Research in digestive system diseases is centered on ulcerative colitis, with trials designed to improve long-term disease control and assess new treatment options for patients with active inflammation. The work aims to support better symptom relief and maintain remission more reliably.

• Ulcerative colitis
• Testing new therapies for chronic bowel inflammation
• Evaluating treatment effectiveness over time
• Focus on sustained disease control

This area reflects a strong interest in treatments that can make daily life easier for people living with ongoing gastrointestinal inflammation.

A large share of the clinical trial activity in Torino involves cancer research, spanning solid tumors and blood cancers. Studies are exploring new therapies, treatment combinations, and maintenance approaches for conditions such as colorectal cancer, ovarian cancer, breast cancer, lymphoma, and multiple myeloma.

• Metastatic colorectal cancer and ovarian cancer
• Breast cancer and diffuse large B-cell lymphoma
• Multiple myeloma and myelodysplastic syndromes
• Testing new anticancer strategies and improving disease control

These trials aim to extend progression-free survival, improve response rates, and support more personalized treatment choices across several major oncology and hematology settings.

Several studies focus on children’s health, especially rare cancers and inherited disorders. Key areas include high-risk neuroblastoma, acute lymphoblastic leukemia, and other conditions where the goal is to improve survival and reduce relapse risk.

• High-risk neuroblastoma
• Pediatric acute lymphoblastic leukemia
• Testing better cancer treatments for children
• Improving outcomes in rare pediatric diseases

These trials support advances in pediatric oncology by evaluating newer treatment approaches and care strategies for young patients with serious illness.

Trials in infectious diseases are examining treatment options for Gram-negative infections and HIV-1, with the aim of improving infection management and supporting long-term viral suppression. The research also includes studies of antimicrobial use in younger patients.

• Gram-negative infections
• HIV-1 infection
• Evaluating treatment effectiveness and safety
• Supporting better infection control and suppression

This field combines antimicrobial research with efforts to make treatment more practical and effective across different patient groups.

Clinical research in female reproductive health addresses both fertility support and pregnancy-related complications. Studies are looking at ways to improve ovarian reserve, assist IVF care, and reduce risks for women with premature rupture of membranes.

• Infertility and assisted reproduction
• Ovarian reserve and fertility support
• Premature rupture of membranes
• Improving reproductive and newborn outcomes

These studies aim to support safer pregnancies and better fertility treatment options for patients and families.

Research in neurology and related muscle disorders includes treatment studies for spinal and bulbar muscular atrophy and approaches to reduce pain from low back pain. The broader goal is to improve function, symptom relief, and quality of life.

• Spinal and bulbar muscular atrophy
• Low back pain
• Testing symptom relief strategies
• Improving mobility and daily functioning

This area reflects a practical focus on conditions that can strongly affect independence and everyday comfort.

A number of trials are dedicated to rare and genetic conditions, including hereditary angioedema and PIK3CA-related overgrowth spectrum. These studies are focused on reducing attacks or managing abnormal tissue growth while improving long-term care.

• Hereditary angioedema
• PIK3CA-related overgrowth
• Evaluating preventive and targeted treatments
• Supporting patients with uncommon chronic disorders

The research is especially important for people with limited treatment options and complex genetic disease.

In skin and connective tissue diseases, trials are studying hidradenitis suppurativa, a painful inflammatory condition that can be difficult to control. The research is aimed at improving disease activity, comfort, and everyday functioning.

• Hidradenitis suppurativa
• Testing new anti-inflammatory treatments
• Assessing safety and tolerability
• Improving quality of life in chronic skin disease

These studies reflect ongoing efforts to find more effective options for persistent dermatologic inflammation.

Research in musculoskeletal disease and related pain conditions includes studies on inflammatory or recurrent pain states where symptom relief is a major priority. The aim is to find treatments that reduce discomfort and help patients return to normal activity sooner.

• Acute low back pain
• Musculoskeletal pain
• Evaluating pain relief and functional improvement
• Assessing patient comfort and tolerability

This work supports better management of common but disabling pain disorders.

Clinical trials in urologic cancer are focusing on upper tract urothelial cancer, with a strong interest in improving tumor control and preserving treatment options. The research also includes advanced and resistant ovarian cancer settings linked to broader female urogenital disease research.

• Upper tract urothelial cancer
• Advanced ovarian cancer
• Testing new targeted and maintenance therapies
• Improving response in hard-to-treat tumors

These studies aim to expand treatment choices in cancers that often require specialized care.

Some studies in Torino are not limited to one disease area but instead examine broader therapeutic techniques and treatment strategies. These trials evaluate how different approaches can improve outcomes, safety, or delivery of care across multiple specialties.

• Therapeutic techniques and equipment-related research
• Comparing standard care with newer treatment approaches
• Improving effectiveness and patient experience
• Supporting more precise clinical decision-making

This kind of research helps refine how treatments are used in everyday practice across a wide range of medical fields.